Thyroid hormones in acute myocardial infarction

Area of Science:

• Endocrinology
• Cardiology
• Metabolic research

Background:

• Thyroid hormones play a crucial role in metabolic regulation.
• Acute myocardial infarction (AMI) is a critical cardiovascular event impacting systemic metabolism.
• Alterations in thyroid hormone profiles during AMI require further investigation.

Purpose of the Study:

• To investigate the dynamic changes in thyroid hormone levels during the acute phase of AMI.
• To correlate these hormonal changes with infarct size and clinical outcomes.
• To elucidate the sequence of thyroid hormone metabolism alterations in AMI patients.

Main Methods:

• Serial measurement of thyroid hormones (T3, rT3, T4, FT4 index, TSH, T3U) over a 2-week period in 34 AMI patients.
• Categorization of patients into complicated and uncomplicated AMI groups based on peak SGOT levels.
• Correlation analysis between hormonal changes and infarct size (peak SGOT).

Main Results:

• A transient increase in plasma rT3 and a decrease in plasma T3 were observed, peaking on day 3 post-AMI.
• Hormonal changes were more pronounced in patients with complicated AMI.
• Significant correlations were found between infarct size and delta rT3, delta T3, and rT3/T3 and rT3/T4 ratios.
• Transient increases in TSH, T4, and FT4 index, along with decreased T3U, were also noted.

Conclusions:

• AMI triggers a sequence of thyroid hormone metabolism changes, including inhibited T4 5'-deiodination, leading to increased rT3 and decreased T3.
• This is followed by TSH secretion, increasing T4 and T3, which is subsequently downregulated by negative feedback.
• Thyroid hormone alterations are linked to infarct severity and may reflect the body's metabolic response to cardiac injury.